Skip to main content

3 Result(s)

within Kenichi Iijima Remove this filter

and

  1. Article

    Open Access

    Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

    Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpos...

    Shinya Fujiki, Kenichi Iijima, Yoshihisa Nakagawa… in Cardiovascular Diabetology (2024)

    Download PDF (1435 KB) View Article

  2. Article

    Open Access

    Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

    Type 2 diabetes (T2DM) is associated with cardiovascular death, including sudden cardiac death due to arrhythmias. Patients with an implantable cardioverter-defibrillator (ICD) are also at high risk of develop...

    Shinya Fujiki, Kenichi Iijima, Masaaki Okabe, Shinichi Niwano… in Diabetes Therapy (2020)

    Download PDF (402 KB) View Article

  3. No Access

    Article

    Relationship between electroanatomical voltage map** characteristics and breakout site of ventricular activation in idiopathic ventricular tachyarrhythmia originating from the right ventricular outflow tract septum

    To assess the electrophysiological characteristics of the breakout site of ventricular activation using electroanatomical voltage map** (EVM) and its relation to the optimal ablation site in idiopathic ventr...

    Hiroshi Furushima, Masaomi Chinushi… in Journal of Interventional Cardiac Electrop… (2012)